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Purpose: To compare delayed-enhancement (DE) magnetic resonance (MR) 
imaging with an elastin-specific contrast agent and unenhanced black-
blood (BB) MR imaging with regard to vessel wall delineation and 
assessment of vascular remodeling and to test the prospective value 
for predicting plaque disruption in a rabbit model of atherosclerosis.
Materials and 
Methods:
All procedures were approved by the animal ethics committee. 
Atherosclerosis was induced in 14 New Zealand White rabbits by 
means of a 1% cholesterol diet and endothelial denudation. Plaque 
disruption was triggered with Russell’s viper venom and histamine. 
Animals with atherosclerosis were imaged before triggering to iden-
tify plaques and vascular remodeling and after triggering to identify 
thrombus. Plaques were classified as nondisrupted (stable) or dis-
rupted (vulnerable). Control rabbits fed a regular diet were imaged 
twice. Unenhanced T1-weighted BB MR imaging, DE MR imaging 
with an elastin-specific contrast agent, and T1 mapping were used to 
assess vascular remodeling and calculate the plaque area and vessel 
wall relaxation rate (R1 = 1/T1). Elastin was quantified by using 
elastica–van Gieson stain. Group comparisons were analyzed with 
the Mann-Whitney or paired t test. Agreement between methods 
was performed with Bland-Altman analysis.
Results: Unenhanced T1-weighted BB MR imaging and DE MR imaging showed 
that, compared with nondisrupted plaques, disrupted plaques had 
larger plaque area (T1-weighted BB MR imaging: 5.1 mm2 vs 5.7 mm2; 
DE MR imaging: 6.0 mm2 vs 7.9 mm2; P , .001) and vessel area (T1-
weighted BB MR imaging: 11.8 mm2 vs 14.3 mm2; DE MR imaging: 
10.8 mm2 vs 13.9 mm2; P < .001) and underwent positive remodeling. 
Assessment of positive remodeling with DE MR imaging enabled better 
prediction of plaque disruption compared to that with unenhanced T1-
weighted BB imaging (sensitivity: 83.7% vs 58.1%). DE MR imaging 
showed a stronger agreement with histologic findings, whereas the ves-
sel area was overestimated with unenhanced T1-weighted BB imaging.
Conclusion: Compared with unenhanced T1-weighted BB MR imaging, DE MR im-
aging with an elastin-specific contrast agent enables more accurate as-
sessment of vascular remodeling in the prediction of vulnerable plaque.
q RSNA, 2014
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segmentation of the wall contours, 
particularly the adventitial vessel 
wall contour, which is crucial for the 
classification of vascular remodeling. 
We performed this study to compare 
DE MR imaging with an elastin-specific 
contrast agent and unenhanced BB MR 
imaging with regard to vessel wall de-
lineation and assessment of vascular 
remodeling and to test the prospective 
value for predicting plaque disruption 
in a rabbit model of atherosclerosis 
(23,25,27).
Materials and Methods
The elastin-specific contrast agent was 
provided by Lantheus Medical Imag-
ing (North Billerica, Mass). D.C.O., 
R.R.C., and S.P.R. are employees of 
Lantheus. Those authors who are not 
employees of or consultants for that in-
dustry (A.P., M.E.A., P.S., A.S., A.I., 
R.M.B.) had control of inclusion of data 
and information that might present 
a conflict of interest for the industry 
authors.
Animal Experiment Protocol
All procedures were approved by the 
animal ethics committee and performed 
according to the United Kingdom An-
imals (Scientific Procedures) Act 1986. 
Fourteen 3-month-old male New Zealand 
White rabbits (Harlan, Wyton, England; 
mean weight, 2.5 kg) were fed a 1% 
cholesterol diet (Special Diet Services, 
imaging of the vessel wall with high 
spatial resolution. MR imaging without 
(6,7) and with (8–17) nonspecific con-
trast agents has been used for in vivo 
plaque characterization, quantification 
of plaque burden, endothelial perme-
ability space, neovascularization, and 
assessment of vascular remodeling. 
Furthermore, MR imaging with target-
ed contrast agents has enabled direct 
visualization of biologic processes (18–
23). However, the MR imaging tech-
niques used are dependent on blood 
flow, the imaging protocols are lengthy, 
and imaging is limited to only certain 
segments of the coronary arteries. 
Consequently, vascular remodeling of 
the coronary arteries has been mainly 
assessed with use of invasive intra-
vascular ultrasonography (US) and/or 
multidetector computed tomography 
(3–5,24). A flow-independent delayed-
enhancement (DE) MR imaging pro-
tocol that was clinically established 
for myocardial infarction imaging and 
has been used for coronary vessel wall 
imaging in humans (9,10,25) could be 
beneficial for the assessment of vascu-
lar remodeling compared with blood 
flow–dependent black-blood (BB) MR 
imaging protocols.
We hypothesize that the abun-
dance of elastin in the vessel wall 
(23,26) would enable more accurate 
A therosclerosis is the major cause of cardiovascular morbidity and mortality. Clinical events such 
as myocardial infarction are caused by 
rupture and/or erosion of “high-risk 
or vulnerable” lesions. Culprit lesions 
are characterized by a thin fibrous cap, 
large plaque burden, small luminal 
area, neovascularization, intraplaque 
hemorrhage, and expansive and/or 
positive vascular remodeling (1–5).
Magnetic resonance (MR) imaging 
is a noninvasive modality that enables 
Implications for Patient Care
 n The use of a DE flow-indepen-
dent protocol that is clinically 
accepted for myocardial infarc-
tion imaging and has been used 
for coronary plaque imaging 
makes the findings of this pre-
clinical study highly translatable 
to vessel wall imaging in humans 
should the contrast agent be ap-
proved for human use.
 n Such application may enable non-
invasive assessment of plaque 
burden and vascular remodeling 
of human atherosclerosis; impor-
tantly, it may enable the study of 
the association of these measure-
ments with plaque progression 
and instability in a serial and/or 
longitudinal manner.
Advances in Knowledge
 n Delayed-enhancement (DE) MR 
imaging with a flow-independent 
sequence after the administra-
tion of an elastin-specific contrast 
agent enabled more accurate as-
sessment of vascular remodeling 
for the detection of “high-risk or 
vulnerable” atherosclerotic 
plaque compared with a standard 
unenhanced T1-weighted black-
blood (BB) sequence in the 
rabbit model of accelerated ath-
erosclerosis and experimentally 
induced plaque disruption (sensi-
tivity: 83.7% vs 58.1%).
 n Bland-Altman comparison of in 
vivo MR imaging and corre-
sponding ex vivo histologic mea-
surements showed that DE MR 
imaging with an elastin-specific 
contrast agent enabled more ac-
curate segmentation of the outer 
and/or adventitial vessel wall 
contour compared with unen-
hanced T1-weighted BB MR im-
aging and, therefore, better as-
sessment of vascular remodeling.
 n DE MR imaging with an elastin-
specific contrast agent showed 
significantly greater uptake in 
atherosclerotic plaque compared 
with normal rabbit vessel walls 
(R1: 2.37 sec−1 vs 1.62 sec−1; P = 
.02), which was in good 
agreement with the histologic 
accumulation of elastin fibers in 
the neointima (36.1% of total 
area vs 26.0% of total area; P = 
.02).
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1000 msec; and 30° flip angle. T1 map-
ping was performed before and after 
administration of the elastin-specific 
contrast agent by using a gradient-echo 
sequence that employs two nonselective 
inversion pulses with inversion times 
ranging from 20 to 2000 msec, followed 
by eight segmented readouts for eight 
individual images. T1 mapping param-
eters were as follows: 3.5/1.8, 10° flip 
angle, 0 3 58-mm field of view, 116 3 
70 matrix, 0.7 3 0.8-mm resolution, 
3-mm-thick sections, 15 sections, and 
one signal acquired (23,32).
After the final MR imaging session, 
rabbits were euthanized with intrave-
nous injection of a bolus of sodium pen-
tobarbital (100 mg/kg) and aortas were 
extracted. During extraction, the aortas 
were marked with suture ligature at 
distances above and below the left renal 
branch that matched the total length 
covered by the in vivo MR imaging sec-
tions. Before the vessels were cut, the 
total length was measured with a ruler, 
and the vessel was marked with ink on 
its anterior site at every 2 cm. After 
extraction, the ligatures were used to 
re-extend the aortas to their physiologic 
length, and the ink marks were used to 
stretch the vessel equally such that the 
ink marks were retained at 2-cm inter-
vals. Subsequently, the tissue was fixed 
with 10% formalin solution (Thermo 
Scientific, Waltham, Mass).
MR Image Analysis
Unenhanced T1-weighted BB MR im-
ages and DE MR images obtained be-
fore pharmacologic triggering were 
evaluated for plaque disruption; post-
trigger images were used only to detect 
mural thrombus. Images from pretrig-
ger unenhanced T1-weighted BB MR 
imaging and DE MR imaging were used 
to manually segment the vessel area 
(defined by the adventitial contour) and 
the lumen area by using image process-
ing software (OsiriX; OsiriX Founda-
tion, Geneva, Switzerland). Plaque area 
was calculated by subtracting lumen 
area from vessel area. Cross-sectional 
narrowing was calculated as follows: 
(plaque area/vessel area) 3 100%.
Vascular remodeling was assessed 
on images from pretrigger unenhanced 
inversion-recovery images, and T1 maps. 
Subsequently, DE inversion-recovery 
images and T1 maps were obtained ap-
proximately 3 hours after intravenous 
administration of 0.2 mmol/kg of the 
elastin-specific contrast agent. Finally, 
the posttriggering MR imaging session, 
performed approximately 10 hours af-
ter the pretrigger session, included ac-
quisition of only scout images, phase-
contrast angiograms, and unenhanced 
T1-weighted BB images to visualize 
thrombus. Only the diseased rabbits 
underwent posttriggering MR imaging.
Phase-contrast angiograms were 
acquired for visualization of the aorta, 
renal branches, and iliac bifurcation 
with the following parameters: repeti-
tion time msec/echo time msec, 20/3; 
15° flip angle; 300 3 150-mm field of 
view; 256 3 122 matrix; 1.2 3 0.6 3 
1-mm resolution; 20 sections; velocity-
encoding value, 150 cm/sec; and two 
signals acquired. The maximum inten-
sity projection images were used to 
plan the subsequent images. Electro-
cardiographically triggered unenhanced 
two-dimensional T1-weighted BB im-
ages were acquired with the following 
parameters: repetition time, two heart-
beats; echo time, 5.4 msec; profile or-
der of low-high; echo train length, six; 
BB delay of 350 msec; 120 3 85-mm 
field of view; 384 3 270 matrix; 0.31 
3 0.31-mm resolution; 4-mm-thick sec-
tions; 25 sections; and two signals ac-
quired. A two-dimensional Look-Locker 
sequence was used to determine the 
optimal inversion time for blood sig-
nal nulling before and after adminis-
tration of the elastin-specific contrast 
agent with the following parameters: 
8.5/3.8, 150 3 150-mm field of view, 
152 3 150 matrix, 1 3 1 3 10-mm 
resolution, and one section. Non–elec-
trocardiographically gated inversion-re-
covery three-dimensional gradient-echo 
axial images were then acquired be-
fore and after administration of the 
elastin-specific contrast agent with the 
following parameters: 20/5.4; 120 3 
85-mm field of view; 520 3 369 matrix; 
0.23 3 0.23-mm resolution; 4-mm-
thick sections; 25 sections; two sig-
nals acquired; repetition time between 
subsequent inversion-recovery pulses, 
Witham, England) for 2 weeks before 
and 6 weeks after balloon injury of the 
abdominal aorta. This was followed by 4 
weeks of normal chow diet (Fig E1 [on-
line]) (11,19,28–31). Diseased rabbits 
received intraperitoneal administration 
of Russell’s viper venom (0.15 mg/kg; En-
zyme Research Laboratories, Swansea, 
United Kingdom), a procoagulant factor, 
followed 30 minutes later by intravenous 
administration of histamine dihydrochlo-
ride (0.02 mg/kg; Sigma-Aldrich, Dorset, 
England), a vasoconstrictor in rabbits, to 
induce plaque disruption and thrombo-
sis. This procedure was repeated twice 
within 4 hours. Two nonballoon injured, 
age- and sex-matched rabbits were fed a 
normal diet for 12 weeks and were used 
as controls. At this time, animals were 
imaged before and after the administra-
tion of the elastin-specific contrast agent 
within the same day.
Elastin-specific MR Contrast Agent
LMI1174 (Lantheus Medical Imaging) 
is a low-molecular-weight (855.95 Da) 
MR contrast agent with moderate spec-
ificity for elastin (half maximal inhibi-
tory concentration, 0.33 mmol/L) and 
similar blood half-life time to that of 
currently used extracellular gadolini-
um-based MR contrast agents (,2% 
injected dose per gram after 60 mi-
nutes and complete blood clearance 
time by 2 hours). It is composed of a 
gadolinium diethylenetriamine pen-
taacetic acid chelate linked to the d-
amino acid d-phenylalanine. At 3.0 T, 
the unbound fraction has a relaxivity 
of 4.3 L ·mmol21 · sec21, whereas the 
bound fraction has a relaxivity of 8.2 L 
· mmol21· sec21 (23,25,27).
In Vivo MR Imaging
The abdominal aorta of control and 
diseased animals was imaged with a 
3.0-T MR unit (Achieva; Philips Health-
care, Best, the Netherlands) and a 
32-channel cardiac coil. Rabbits re-
ceived general anesthesia and were 
imaged in the supine position before 
and after pharmacologic triggering. 
The pretrigger MR imaging session in-
cluded acquisition of precontrast (un-
enhanced) scout phase-contrast MR 
angiograms, T1-weighted BB images, 
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to identify independent predictors of 
plaque disruption, with the presence 
or absence of thrombus as the out-
come variable. Data are presented as 
medians and interquartile ranges. P , 
.05 was considered indicative of a sig-
nificant difference.
Results
MR Imaging of Atherosclerosis and 
Plaque Classification
Atherosclerosis was observed in all 14 
injured and cholesterol-fed rabbits, and 
thrombosis occurred in seven (50%). No 
atherosclerosis was observed in control 
rabbits. Posttriggered MR images from 
the 14 diseased animals demonstrated 
that 42 of 284 vessel wall segments or 
sections (14.8%) had thrombus and 242 
(85.2%) did not. Representative unen-
hanced T1-weighted BB MR images and 
histologic images of the aorta from the 
same animal are shown in Figure 1. 
Vessel wall thickening (vessel wall area: 
6.0 mm2 for nondisrupted plaque and 
7.0 mm2 for disrupted plaque) is seen 
on the pretriggered images, whereas 
mural thrombus is seen only on the 
posttriggered image of the disrupted 
plaque. The vessel wall area was 2.4 
mm2 (range, 2.2–2.4 mm2) in control 
animals and 6.7 mm2 (range, 5.3–8.2 
mm2) in diseased animals.
MR Imaging with the Elastin-Binding 
Contrast Agent
Strong aortic wall enhancement was 
observed on DE MR images in both 
control and diseased animals (Fig 2). 
Vessel wall contours and thickness were 
more readily visualized on DE MR im-
ages (Fig 2, B, F, C, and G) than on 
precontrast images (Fig 2, A and E). 
Contrast enhancement of the vessel 
wall was quantified by using R1 relax-
ation maps (Fig 2, D and H). Quanti-
tative measurements with pretrigger 
unenhanced T1-weighted BB images 
and DE MR images demonstrated a 
significantly larger vessel, lumen, and 
plaque area and a similar percentage of 
cross-sectional narrowing in disrupted 
compared with nondisrupted plaque 
from diseased animals (Table 1).
the vascular elastin area, which was 
expressed in square millimeters or as 
a percentage of total elastin ([elastica 
van Gieson–stained area/adventitial 
area] 3 100). Control aorta (six seg-
ments from the two control rabbits) 
and diseased aorta (20 plaque-bearing 
segments from the 14 diseased ani-
mals) were used for the analysis of 
the percentage elastin content of the 
tissue. For registration of the in vivo 
MR images and histologic sections, the 
distance of the proximal end of each 
segment from the renal branches and 
iliac bifurcation, the gross morphol-
ogy, and internal plaque and/or throm-
bus landmarks visible on both the 
MR and histologic images were used 
as references. Histologic analysis was 
performed by A.P., who has more than 
10 years of experience.
Statistical Analysis
Software (The Statistical Package for 
the Social Sciences 19.0; IBM, Somers, 
NY) was used for statistical analysis. 
For two-group comparisons, contin-
uous variables were compared with 
a Mann-Whitney nonparametric test 
(MR imaging–derived measurements 
between stable vs vulnerable plaque, 
R1 after contrast material adminis-
tration between control and diseased 
aortas, percentage total elastin in con-
trol vs diseased sections). R1 values 
before and after contrast material ad-
ministration were compared by using a 
paired t test. Correlation analysis was 
performed by using the Spearman test. 
The agreement between in vivo MR 
imaging measurements and histologic 
findings was assessed by using Bland-
Altman plots. The predictive value 
of unenhanced T1-weighted BB and 
DE MR imaging in the prediction of 
plaque disruption was assessed by us-
ing sensitivity, specificity, positive and 
negative predictive values, and the re-
ceiver operating characteristic curve. 
The McNemar exact test was used to 
compare the sensitivities, specificities, 
and accuracies of positive remodeling 
assessed with DE MR imaging and un-
enhanced T1-weighted BB imaging to 
correctly identify disrupted plaque. 
Logistic regression analysis was used 
T1-weighted BB MR imaging and DE 
MR imaging on the basis of the outer 
vessel wall area measured in the ab-
dominal aorta. Two times the standard 
deviation from the linear regression 
line of the vessel area measured on 
consecutive sections covering the ab-
dominal aorta was used as the cutoff 
point. Vascular remodeling was classi-
fied as positive, negative, or interme-
diate when the vessel area was larger 
than the upper 95% confidence band 
(vessel area more than +2 SD), smaller 
than the lower 95% confidence band 
(vessel area less than 22 SD), or within 
the 95% confidence band (vessel area 
was at least 22 SD and less than or 
equal to +2 SD), respectively. Pretrig-
ger T1 maps were used to calculate 
the vessel wall relaxation rate (R1, in 
sec21) before and after administration 
of the elastin-specific contrast agent on 
a pixel-by-pixel basis by using in-house 
software (Matlab, Natick, Mass) (23). 
Posttrigger unenhanced T1-weighted 
BB images were only used to identify 
the presence or absence of thrombus 
as an end point for the classification of 
plaques as disrupted or nondisrupted, 
respectively (11,31). Analysis of MR 
images was performed by two indepen-
dent readers (A.P. and M.E.A., both 
with more than 10 years of experience).
Histologic Analysis
En face preparations of the aorta 
were used to visualize atherosclerosis, 
vascular remodeling, and thrombus. 
Transverse cryosections (10 mm thick) 
were collected throughout the length 
of each segment at 500-mm intervals 
and stained with Masson trichrome for 
cellular components collagen, throm-
bus, and vascular measurements. 
Elastica–van Gieson stain was used to 
visualize the elastin fibers and calcu-
late the elastin content (neointima and 
media area). Vessel and lumen areas, 
which are defined by the adventitial 
and luminal contours, were manually 
segmented with ImageJ software (Na-
tional Institutes of Health, Bethesda, 
Md). The plaque area was calculated 
from the difference of these measure-
ments. Computer-assisted color image 
analysis (ImageJ) was used to quantify 
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Figure 1
Figure 1: Images of atherosclerosis and disrupted and nondisrupted plaque. A, D, Cross-sectional unenhanced T1-weighted BB 
images obtained before pharmacologic triggering show vessel wall thickening. B, E, Corresponding images obtained after triggering 
for plaque disruption show presence of thrombus (arrow) overlying disrupted plaque. C, F, Photomicrographs (Masson trichrome stain; 
original magnification, ×2.5) show atherosclerosis and thrombus.
Figure 2
Figure 2:  A, E, Cross-sectional precontrast MR images. B, F, Corresponding DE MR images obtained after administration of elastin-spe-
cific contrast agent. C, G, DE MR images fused with angiographic images. D, H, Corresponding R1 maps obtained after administration of 
elastin-specific contrast agent. Uptake of elastin-specific contrast agent and R1 values are higher in diseased compared with control aortas.
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detection of plaque disruption as mea-
sured on unenhanced T1-weighted BB 
images and DE MR images is shown in 
Table 2 and Tables E1 and E2 (online). 
The cutoff value for plaque area (5.7 
mm2) was calculated on the basis of the 
receiver operating characteristic curve 
as the value corresponding to the high-
est sensitivity and specificity in the pre-
diction of plaque disruption. The pres-
ence of positive vascular remodeling at 
DE MR imaging had a higher sensitivity 
than the presence of positive vascular 
remodeling at unenhanced T1-weighted 
BB MR imaging in the detection of dis-
rupted plaque (P = .04), whereas the 
specificity (P = .08) and accuracy (P = 
.9) were similar between the two im-
aging sequences. Logistic regression 
analysis identified plaque area and pos-
itive remodeling measured with DE MR 
imaging as predictors of plaque disrup-
tion (Tables E1, E2 [online]). There was 
good agreement between findings at in 
vivo MR imaging and ex vivo histologic 
examination, as shown with Bland-Alt-
man analysis (Fig E3 [online]).
Discussion
Our study demonstrates that the use of 
a flow-independent inversion-recovery 
sequence for DE vessel wall imaging af-
ter administration of an elastin-specific 
MR contrast agent enabled more accu-
rate assessment of vascular remodeling 
and detection of plaques with a higher 
likelihood to disrupt compared with the 
unenhanced T1-weighted BB images in 
a rabbit model of accelerated athero-
sclerosis and experimentally induced 
plaque disruption.
The specificity of the elastin-specific 
MR contrast agent was shown in ex vivo 
and in vivo settings (23,25,27). A gado-
linium 153 (153Gd)–labeled elastin agent 
showed preferential binding to purified 
elastin and little binding to bovine se-
rum albumin and chondroitin-6-sulfate 
(25). Ex vivo and in vivo experiments 
showed that a 153Gd-labeled elastin 
agent had high binding to normal and 
plaque-bearing arteries and co-local-
ized with elastin fibers while showing 
little binding to rabbit vena cava with 
significantly lower elastin content (27). 
= 0.74; P , .01; 95% confidence inter-
val: 0.29, 0.92; Fig E2, C [online]).
Disrupted Plaques Undergo Positive 
Vascular Remodeling
Representative pretrigger DE MR im-
ages obtained after administration of 
the elastin-specific contrast agent at 
four levels of the aorta (lines on the ex 
vivo specimen [Fig 4, E]) show focal 
enlargement of the vessel area (Fig 4, 
A–D). Positive remodeling observed on 
DE MR images was verified histologi-
cally (Fig 4, E), and the thrombus was 
confirmed when the vessel was opened 
longitudinally (Fig 4, F). A representa-
tive scatterplot from one animal shows 
the changes in the vessel area along 
the aorta, starting from the left renal 
branch (0 mm) until the iliac bifurca-
tion (87 mm), and the classification of 
vascular remodeling (Fig 4, G). Two 
vessel wall segments (regions 1 and 2) 
showed enlarged vessel area (greater 
than mean +2 SD) and were classified 
as showing positive remodeling. Both 
regions contained plaques that disrupt-
ed after pharmacologic triggering. The 
rest of the data points correspond to 
regions of the aorta that contained non-
disrupted plaques.
The predictive value of positive 
remodeling and plaque area, inde-
pendently or in combination, in the 
Histologic Examination
Elastin fibers (purple staining) were 
present in the media of control vessels 
(Fig 3, A and D) and in the neointima 
of atherosclerotic vessels (Fig 3, B, C, 
E, and F), as seen with elastica–van Gie-
son staining (percentage of total area: 
26.0% [range, 25.0%–28.0%] vs 36.1% 
[range, 22.8%–47.8%], P = .02; Fig 3, 
G).
Vessel Wall Relaxation Rate and 
Enhancement Area at MR Imaging
Vessel wall R1 (Fig E2, A [online]) on 
images obtained after administration of 
the elastin-specific contrast agent was 
significantly higher than that on precon-
trast images (P , .01). Vessel wall R1 
was also significantly higher in diseased 
compared with control vessels (median 
R1 for abdominal aorta: 2.37 sec21 
[range, 2.0–2.7 sec21] vs 1.62 sec21 
[range, 1.48–1.72 sec21], P = .02; me-
dian R1 for thoracic aorta: 1.95 sec21 
[range, 1.8–2.2 sec21] vs 1.6 sec21 
[range, 1.5–1.7 sec21], P = .03). The 
vessel wall R1 correlated strongly with 
the percentage total elastin content (r = 
0.88; P , .01; 95% confidence interval: 
0.62, 0.97; Fig E2, B [online]). Further-
more, the total elastin area showed a 
positive correlation with the enhanced 
area measured with DE MR imaging (r 
Table 1
Quantitative MR Imaging Measurements of Nondisrupted and Disrupted Plaques in 
Diseased Animals
Variable Nondisrupted Plaque (n = 242)* Disrupted Plaque (n = 42)* P Value
Unenhanced T1-weighted BB imaging
 Vessel area (mm2) 11.8 (9.4–13.9) 14.3 (11.0–20.6) ,.001
 Lumen area (mm2) 6.4 (5.0–8.2) 8.1 (5.7–9.8) .002
 Plaque area (mm2) 5.1 (4.2–6.2) 5.7 (4.8–8.9) .001
 Cross-sectional narrowing (%) 44.3 (37.4–50.1) 46.6 (34.8–50.5) .62
DE MR imaging 
 Vessel area (mm2) 10.8 (8.9–12.8) 13.9 (10.9–16.9) ,.001
 Lumen area (mm2) 4.4 (3.4–6.5) 6.4 (4.6–8.4) ,.001
 Plaque area (mm2) 6.0 (5.2–7.0) 7.9 (6.0–9.7) ,.001
 Cross-sectional narrowing (%) 55.9 (47.4–63.1) 54.6 (45.2–59.9) .22
Phase-contrast angiography
 Lumen area (mm2) 5.3 (4.6–6.6) 5.6 (4.9–7.4) .10
* Data are medians, with interquartile ranges in parentheses.
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and thrombosis at a precise time point 
provides a functional end point to clas-
sify plaque as nondisrupted and/or sta-
ble or disrupted and/or vulnerable. To 
this end, we were able to extent our 
study to compare the predictive value 
of the DE MR imaging after adminis-
tration of an elastin-specific MR con-
trast agent with the commonly used 
unenhanced T1-weighted BB proto-
col in classifying vascular remodeling 
(negative, intermediate, and positive) 
elastin content measured at histologic 
examination.
Herein, we further corroborated 
the finding that plaque progression is 
associated with the histologic accu-
mulation of elastin fibers in the neo-
intima that results in a significantly 
greater uptake of an elastin-specific 
MR contrast agent in atherosclerotic 
plaque compared with normal rabbit 
aorta. Importantly, the ability to ex-
perimentally induce plaque disruption 
An elastin-specific MR contrast agent 
was used for the first time to monitor 
image plaque burden in atherosclerotic 
apolipoprotein E–deficient mice (23) 
and later to image coronary artery re-
modeling after stent-induced injury in 
a swine model (25). In both studies, 
plaque burden measurements and the 
extent of vascular damage as assessed 
with DE MR imaging after administra-
tion of an elastin-specific contrast agent 
were in agreement with the vascular 
Figure 3
Figure 3: Histologic characteristics of elastin fibers. D, E, and F are magnifications (original magnification, ×10) of 
boxes in A, B, and C (original magnification, ×2.5). All photomicrographs were stained with Masson trichrome. A, D, 
Photomicrographs of control vessels show well-organized elastic fibers (purple-black) in media. Arrows in D indicate 
internal and external elastic lamina. B, E, C, F, Photomicrographs of diseased vessel walls show deposition of elastic 
fibers in neointima (N) overlying the internal elastic lamina (IEL). G, Quantification of percentage total elastin area. A = 
adventitia, EEL = external elastic lamina, EvG = elastica–van Gieson, FC = fibrous cap, L = lumen, M = media, T = 
thrombus.
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Figure 4
Figure 4: Positive vascular remodeling in disrupted plaques. A–D, DE MR images obtained after administration of 
elastin-specific contrast agent show positive remodeling, as defined by enlargement of vessel area (yellow contours). E, 
Corresponding en face photograph verifies presence of positive vascular remodeling. F, En face photograph of longitudi-
nally open vessel shows thrombus (arrow) attached to vessel wall at proximal end of positive remodeling. G, Scatterplot 
shows change in vessel area measured on consecutive slices along aorta, starting from left renal branch (0 mm) to iliac 
bifurcation (86 mm). Two regions of the vessel wall underwent positive remodeling, with vessel areas falling above the 
mean + 2 SD margin. Both plaques disrupted after triggering. Four of seven sections covering the vulnerable region 2 
are illustrated in A–D.
Table 2
Predictive Value of Positive Remodeling and Plaque Area in the Detection of Plaque Disruption
Variable Sensitivity (%) Specificity (%) PPV (%) NPV (%) Diagnostic Accuracy (%)
Positive remodeling
 DE MR imaging 83.7 (69.3, 93.2) 91.8 (88.2, 94.6) 59.0 (45.7, 71.4) 97.6 (95.0, 99.0) 90.8 ( 87.6, 92.9)
 Unenhanced T1-weighted BB imaging 58.1 (42.1, 73.0) 83.0 (77.7, 87.6) 37.9 (26.2, 50.7) 91.8 (87.3, 95.0) 79.3 (75.0, 83.2)
Plaque area at DE MR imaging* 88.4 (74.90, 96.07) 41.5 (35.17, 48.10) 21.6 (15.76, 28.41) 95.2 (89.03, 98.39) 48.7 (44.7, 51.0)
Both positive remodeling and plaque area  
 at DE MR imaging*
72.0 ( 56.33, 84.66) 92.8 (88.72, 95.75) 64.6 (49.46, 77.83) 94.8 (91.10, 97.28) 89.6 (85.6, 92.8)
Note.–Data were obtained in 284 sections (242 nondisrupted and 42 disrupted plaques). Numbers in parentheses are 95% confidence intervals. Assessment of positive remodeling with DE MR imaging 
after administration of the elastin-specific contrast agent enabled a higher sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy in the detection of plaque 
disruption compared to that with unenhanced T1-weighted BB imaging. The positive predictive value increased when both positive remodeling and plaque area (5.7 mm2) were present. NPV = 
negative predictive value, PPV = positive predictive value.
* The cutoff value for plaque area was 5.7 mm2.
for the detection of “high risk and/or 
vulnerable” plaque.
Both unenhanced T1-weighted BB 
images and DE MR images obtained 
with an elastin-specific MR contrast 
agent showed that a larger vessel, lu-
men, and plaque area are associated 
with disrupted plaque. However, as-
sessment of vascular remodeling with 
the DE MR images showed higher pre-
dictive values for identifying disrupted 
plaques compared with the unenhanced 
T1-weighted BB technique. The strong 
uptake of the elastin-specific contrast 
agent in the aortic wall and the lack 
of uptake in the adjacent inferior vena 
cava and the paravertebral muscle ow-
ing to the inherently lower concentra-
tion or absence of elastin fibers, respec-
tively, improved the segmentation of 
the adventitial vessel wall contour that 
is essential for accurate assessment of 
vascular remodeling (23,25,27). As-
sessment of remodeling with contrast 
material–enhanced MR imaging by us-
ing the standardized cutoff values es-
tablished with intravascular US, instead 
of the 2 SD cutoff value as used herein, 
was previously reported by using the 
same rabbit model (11). In that study, 
vascular remodeling was assessed by 
using a bright-blood sequence after ad-
ministration of a nonspecific gadolinium 
diethylenetriamine pentaacetic acid 
compound (Magnevist; Bayer Health-
care, Berlin, Germany) in which vessel 
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logic characterization with gadolinium-en-
hanced double-oblique MR imaging—initial 
results. Radiology 2002;223(2):566–573.
 9. Maintz D, Ozgun M, Hoffmeier A, et al. Se-
lective coronary artery plaque visualization 
and differentiation by contrast-enhanced 
inversion prepared MRI. Eur Heart J 
2006;27(14):1732–1736.
 10. Yeon SB, Sabir A, Clouse M, et al. Delayed-
enhancement cardiovascular magnetic 
resonance coronary artery wall imaging: 
comparison with multislice computed to-
mography and quantitative coronary angiog-
raphy. J Am Coll Cardiol 2007;50(5):441–
447.
 11. Phinikaridou A, Ruberg FL, Hallock KJ, et 
al. In vivo detection of vulnerable athero-
sclerotic plaque by MRI in a rabbit model. 
Circ Cardiovasc Imaging 2010;3(3):323–
332.
 12. Pedersen SF, Thrysøe SA, Paaske WP, et al. 
CMR assessment of endothelial damage and 
angiogenesis in porcine coronary arteries 
using gadofosveset. J Cardiovasc Magn Re-
son 2011;13:10.
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